These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17511705)

  • 1. The use of human experience data in the EU risk assessment process.
    Money CD
    Risk Anal; 2007 Apr; 27(2):387-96. PubMed ID: 17511705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priority setting for risk assessment--the benefit of human experience.
    Alonzo C; Laborde A
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):692-6. PubMed ID: 16153990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessments of direct human exposure: the approach of EU risk assessments compared to scenario-based risk assessment.
    Wormuth M; Demou E; Scheringer M; Hungerbühler K
    Risk Anal; 2007 Aug; 27(4):979-90. PubMed ID: 17958505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of user safety, exposure and risk to veterinary medicinal products in the European Union.
    Woodward KN
    Regul Toxicol Pharmacol; 2008 Feb; 50(1):114-28. PubMed ID: 18060673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental risk assessment of zinc in European freshwaters: a critical appraisal.
    Van Sprang PA; Verdonck FA; Van Assche F; Regoli L; De Schamphelaere KA
    Sci Total Environ; 2009 Oct; 407(20):5373-91. PubMed ID: 19631966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk estimation for carcinogens based on epidemiological data: a structured approach, illustrated by an example on chromium.
    Goldbohm RA; Tielemans EL; Heederik D; Rubingh CM; Dekkers S; Willems MI; Dinant Kroese E
    Regul Toxicol Pharmacol; 2006 Apr; 44(3):294-310. PubMed ID: 16497421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental exposure scenarios: development, challenges and possible solutions.
    Ahrens A; Traas TP
    J Expo Sci Environ Epidemiol; 2007 Dec; 17 Suppl 1():S7-15. PubMed ID: 18000528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are occupational exposure limits becoming more alike within the European Union?
    Schenk L; Hansson SO; Rudén C; Gilek M
    J Appl Toxicol; 2008 Oct; 28(7):858-66. PubMed ID: 18381691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges of exposure assessment for health studies in the aftermath of chemical incidents and disasters.
    Bongers S; Janssen NA; Reiss B; Grievink L; Lebret E; Kromhout H
    J Expo Sci Environ Epidemiol; 2008 Jul; 18(4):341-59. PubMed ID: 18461091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The possibilities for the EU-wide use of similar ecological risk-based soil contamination assessment tools.
    Swartjes FA; Carlon C; de Wit NH
    Sci Total Environ; 2008 Dec; 406(3):523-9. PubMed ID: 18762322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead contamination in Uruguay: the "La Teja" neighborhood case.
    Mañay N; Cousillas AZ; Alvarez C; Heller T
    Rev Environ Contam Toxicol; 2008; 195():93-115. PubMed ID: 18418955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative test methods in inhalation toxicology: challenges and opportunities.
    Costa DL
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):105-9. PubMed ID: 18486462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Manoguerra AS; Erdman AR; Woolf AD; Chyka PA; Caravati EM; Scharman EJ; Booze LL; Christianson G; Nelson LS; Cobaugh DJ; Troutman WG;
    Clin Toxicol (Phila); 2008 Aug; 46(7):661-76. PubMed ID: 18608263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Legislation for the control of avian influenza in the European union.
    Pittman M; Laddomada A
    Zoonoses Public Health; 2008; 55(1):29-36. PubMed ID: 18201324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health risk assessment procedures for endocrine disrupting compounds within different regulatory frameworks in the European Union.
    Beronius A; Rudén C; Hanberg A; Håkansson H
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):111-22. PubMed ID: 19500631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving uncertainty analysis in European Union risk assessment of chemicals.
    Verdonck FA; Souren A; van Asselt MB; Van Sprang PA; Vanrolleghem PA
    Integr Environ Assess Manag; 2007 Jul; 3(3):333-43. PubMed ID: 17695106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycol ethers: a ubiquitous family of toxic chemicals: a plea for REACH regulation.
    Cicolella A
    Ann N Y Acad Sci; 2006 Sep; 1076():784-9. PubMed ID: 17119255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.